Lack of cross-protection against Bordetella holmesii after pertussis vaccination

Emerging Infectious Diseases

Volumn 18, Issue 11, 2012, Pages 1771-1779

  Zhang, Xuqing ^a   Weyrich, Laura S ^a   Lavine, Jennie S ^a   Karanikas, Alexia T ^a   Harvill, Eric T ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; GAMMA INTERFERON; INTERLEUKIN 10;

ADOLESCENT; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIUM ISOLATION; BORDETELLA; BORDETELLA HOLMESII; BORDETELLA PERTUSSIS; BORDETELLOSIS; CHILD; CLINICAL ARTICLE; CROSS PROTECTION; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFANT; MOUSE; NEWBORN; NONHUMAN; PHYLOGENY; PRESCHOOL CHILD; SCHOOL CHILD; SPLEEN CELL; T LYMPHOCYTE; VACCINATION; VACCINE FAILURE; WESTERN BLOTTING;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; BORDETELLA; BORDETELLA INFECTIONS; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; CROSS PROTECTION; DISEASE SUSCEPTIBILITY; GENES, BACTERIAL; HUMANS; INFANT; INFANT, NEWBORN; MASSACHUSETTS; MICE; MIDDLE AGED; PERTUSSIS VACCINE; PHYLOGENY; SPLEEN; T-LYMPHOCYTES; WHOOPING COUGH; YOUNG ADULT;

EID: 84867874275     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1811.111544     Document Type: Article

References (40)

1. Hoppe JE. Update on respiratory infection caused by Bordetella parapertussis. Pediatr Infect Dis J. 1999;18:375-81. http://dx.doi. org/10.1097/00006454-199904000-00016
2. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005;18:326-82. http://dx.doi.org/10.1128/CMR.18.2.326-382.2005
3. Cherry JD, Brunell PA, Golden GS, Karson DT. Report of the task force on pertussis and pertussis immunization-1988. Pediatrics. 1988;81:939.
4. Centers for Disease Control and Prevention. Pertussis-United States, 1997-2000. JAMA. 2002;287:977-9. http://dx.doi.org/10.1001/jama.287.8.977
5. Celentano LPMM, Paramatti D, Salmaso S, Tozzi AE; EUVAC-NET Group. Resurgence of pertussis in Europe. Pediatr Infect Dis J. 2005;24:761-5. http://dx.doi.org/10.1097/01. inf.0000177282.53500.77
6. Kamiya H, Otsuka N, Ando Y, Odaira F, Yoshino S, Kawano K, et al. Transmission of Bordetella holmesii during pertussis outbreak, Japan. Emerg Infect Dis. 2012;18:1166-9. http://dx.doi.org/10.3201/eid1807.120130
7. Miranda C, Porte L, Garcia P. Bordetella holmesii in nasopharyngeal samples from Chilean patients with suspected Bordetella pertussis infection. J Clin Microbiol. 2012;50:1505, author reply 6. http://dx.doi.org/10.1128/JCM.06747-11
8. Mooi FR, Bruisten S, Linde I, Reubsaet F, Heuvelman K, van der Lee S, et al. Characterization of Bordetella holmesii isolates from patients with pertussis-like illness in The Netherlands. FEMS Immunol Med Microbiol. 2012;64:289-91. http://dx.doi.org/10.1111/j.1574-695X.2011.00911.x
9. Njamkepo E, Bonacorsi S, Debruyne M, Gibaud SA, Guillot S, Guiso N. Significant finding of Bordetella holmesii DNA in nasopharyngeal samples from French patients with suspected pertussis. J Clin Microbiol. 2011;49:4347-8. http://dx.doi.org/10.1128/JCM.01272-11
10. Weyant RS, Hollis DG, Weaver RE, Amin MF, Steigerwalt AG, O'Connor SP, et al. Bordetella holmesii sp. nov., a new gramnegative species associated with septicemia. J Clin Microbiol. 1995;33:1-7.
11. Guthrie JL, Robertson AV, Tang P, Jamieson F, Drews SJ. Novel duplex real-time PCR assay detects Bordetella holmesii in specimens from patients with pertussis-like symptoms in Ontario, Canada. J Clin Microbiol. 2010;48:1435-7. http://dx.doi.org/10.1128/JCM.02417-09
12. Russell FM, Davis JM, Whipp MJ, Janssen PH, Ward PB, Vyas JR, et al. Severe Bordetella holmesii infection in a previously healthy adolescent confirmed by gene sequence analysis. Clin Infect Dis. 2001;33:129-30. http://dx.doi.org/10.1086/320892
13. Dörbecker C, Licht C, Korber F, Plum G, Haefs C, Hoppe B, et al. Community-acquired pneumonia due to Bordetella holmesii in a patient with frequently relapsing nephrotic syndrome. J Infect. 2007;54:e203-5. http://dx.doi.org/10.1016/j.jinf.2006.11.004
14. Njamkepo E, Delisle F, Hagege I, Gerbaud G, Guiso N. Bordetella holmesii isolated from a patient with sickle cell anemia: analysis and comparison with other Bordetella holmesii isolates. Clin Microbiol Infect. 2000;6:131-6. http://dx.doi.org/10.1046/j.1469-0691.2000.00032.x
15. Greig JR, Gunda SS, Kwan JTC. Bordetella holmesii bacteraemia in an individual on haemodialysis. Scand J Infect Dis. 2001;33:716-7. http://dx.doi.org/10.1080/00365540110026826
16. Diavatopoulos DA, Cummings CA, van der Heide HG, van Gent M, Liew S, Relman DA, et al. Characterization of a highly conserved island in the otherwise divergent Bordetella holmesii and Bordetella pertussis genomes. J Bacteriol. 2006;188:8385-94. http://dx.doi. org/10.1128/JB.01081-06
17. Shepard CW, Daneshvar MI, Kaiser RM, Ashford DA, Lonsway D, Patel JB, et al. Bordetella holmesii bacteremia: a newly recognized clinical entity among asplenic patients. Clin Infect Dis. 2004;38:799-804. http://dx.doi.org/10.1086/381888
18. McCavit TL, Grube S, Revell P, Quinn CT. Bordetella holmesii bacteremia in sickle cell disease. Pediatr Blood Cancer. 2008;51:814-6. http://dx.doi.org/10.1002/pbc.21712
19. Monnier S, Therby A, Couzon B, Doucet-Populaire F, Greder-Belan A. Bordetella holmesii bacteremia in a 26-year-old patient with sickle cell disease [article in French]. Med Mal Infect. Epub 2009 Jul 7.
20. Lindquist SW, Weber DJ, Mangum ME, Hollis DG, Jordan J. Bordetella holmesii sepsis in an asplenic adolescent. Pediatr Infect Dis J. 1995;14:813-5. http://dx.doi.org/10.1097/00006454-199509000-00020
21. Mazengia E, Silva EA, Peppe JA, Timperi R, George H. Recovery of Bordetella holmesii from patients with pertussis-like symptoms: use of pulsed-field gel electrophoresis to characterize circulating strains. J Clin Microbiol. 2000;38:2330-3.
22. Tang YW, Hopkins MK, Kolbert CP, Hartley PA, Severance PJ, Persing DH. Bordetella holmesii-like organisms associated with septicemia, endocarditis, and respiratory failure. Clin Infect Dis. 1998;26:389-92. http://dx.doi.org/10.1086/516323
23. Yih WK, Silva EA, Ida J, Harrington N, Lett SM, George H. Bordetella holmesii-like organisms isolated from Massachusetts patients with pertussis-like symptoms. Emerg Infect Dis. 1999;5:441-3. http://dx.doi.org/10.3201/eid0503.990317
24. Stibitz S, Yang MS. Subcellular localization and immunological detection of proteins encoded by the vir locus of Bordetella pertussis. J Bacteriol. 1991;173:4288-96.
25. Preston A, Allen AG, Cadisch J, Thomas R, Stevens K, Churcher CM, et al. Genetic basis for lipopolysaccharide O-antigen biosynthesis in bordetellae. Infect Immun. 1999;67:3763-7.
26. von Koenig CH, Tacken A, Finger H. Use of supplemented Stainer-Scholte broth for the isolation of Bordetella pertussis from clinical material. J Clin Microbiol. 1988;26:2558-60.
27. Stainer DW, Scholte MJ. A simple chemically defined medium for the production of phase I Bordetella pertussis. J Gen Microbiol. 1970;63:211-20. http://dx.doi.org/10.1099/00221287-63-2-211
28. Gopinathan L, Kirimanjeswara GS, Wolfe DN, Kelley ML, Harvill ET. Different mechanisms of vaccine-induced and infectioninduced immunity to Bordetella bronchiseptica. Microbes Infect. 2007;9:442-8. http://dx.doi.org/10.1016/j.micinf.2007.01.001
29. Kirimanjeswara GS, Agosto LM, Kennett MJ, Bjornstad ON, Harvill ET. Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis. J Clin Invest. 2005;115:3594-601. http://dx.doi.org/10.1172/JCI24609
30. Kirimanjeswara GS, Mann PB, Harvill ET. Role of antibodies in immunity to Bordetella infections. Infect Immun. 2003;71:1719-24. http://dx.doi.org/10.1128/IAI.71.4.1719-1724.2003
31. Pilione MRHE. The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance. Infect Immun. 2006;74:1043-9. http://dx.doi.org/10.1128/IAI.74.2.1043-1049.2006
32. Pishko EJ, Kirimanjeswara GS, Pilione MR, Gopinathan L, Kennett MJ, Harvill ET. Antibody-mediated bacterial clearance from the lower respiratory tract of mice requires complement component C3. Eur J Immunol. 2004;34:184-93. http://dx.doi.org/10.1002/eji.200324234
33. Zhang X, Rodriguez ME, Harvill ET. O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies. PLoS ONE. 2009;4:e6989. http://dx.doi.org/10.1371/journal.pone.0006989
34. Wolfe DNKG, Harvill ET. Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity. Infect Immun. 2005;73:6508-13. http://dx.doi.org/10.1128/IAI.73.10.6508-6513.2005
35. Wolfe DN, Goebel EM, Bjornstad ON, Restif O, Harvill ET. The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity. Infect Immun. 2007;75:4972-9. http://dx.doi.org/10.1128/IAI.00763-07
36. Myc A, Buck J, Gonin J, Reynolds B, Hammerling U, Emanuel D. The level of lipopolysaccharide-binding protein is significantly increased in plasma in patients with the systemic inflammatory response syndrome. Clin Diagn Lab Immunol. 1997;4:113-6.
37. Wolfe DN, Kirimanjeswara GS, Goebel EM, Harvill ET. Comparative role of immunoglobulin A in protective immunity against the Bordetellae. Infect Immun. 2007;75:4416-22. http://dx.doi. org/10.1128/IAI.00412-07
38. Goebel EM, Zhang X, Harvill ET. Bordetella pertussis infection or vaccination substantially protects mice against B. bronchiseptica infection. PLoS ONE. 2009;4:e6778. http://dx.doi.org/10.1371/journal. pone.0006778
39. Mills KH. Immunity to Bordetella pertussis. Microbes Infect. 2001;3:655-77. http://dx.doi.org/10.1016/S1286-4579(01)01421-6
40. Harvill ET, Cotter PA, Miller JF. Pregenomic comparative analysis between Bordetella bronchiseptica RB50 and Bordetella pertussis Tohama I in murine models of respiratory tract infection. Infect Immun. 1999;67:6109-18.